| Metric | Value ($ M) | Q1 FY25 |
|---|---|---|
| Revenue | 12.31 | 6.8% |
| Total Income | 12.31 | 6.8% |
| Expenditure | 6.30 | 6.3% |
| PBT | — | |
| Net Profit | 5.78 | 8.3% |
| OPM | 48.86% | 0.30pp |
| NPM | 46.92% | 0.75pp |
| EPS | 0.28 | 9.7% |
NewLake Capital Partners Reports Q1 2026 Revenue of $12.3 Million
08 May 2026 · 8 May, 3:42 pm
Summary
NewLake Capital Partners announced its financial results for the first quarter ended March 31, 2026. Total revenue for the quarter was $12.3 million. Net income attributable to common stockholders totaled $5.8 million, or $0.28 per share. The company's President and CEO, Anthony Coniglio, noted that the first quarter results were in line with expectations, highlighted by 100% collection of contractual rent during the period. The company remains focused on disciplined capital management and proactively reducing risk.
Key Highlights
- 1
NewLake Capital Partners reported total revenue of $12.3 million for the first quarter of 2026.
- 2
Net income attributable to common stockholders totaled $5.8 million, or $0.28 per share, for Q1 2026.
- 3
Funds From Operations (FFO) totaled $9.7 million, or $0.46 per share of common stock, for the first quarter.
- 4
Adjusted Funds From Operations (AFFO) totaled $10.1 million, or $0.48 per share of common stock, in Q1 2026.
- 5
The company declared a first quarter dividend of $0.43 per share of common stock, equivalent to an annualized dividend of $1.72 per common share.
- 6
As of March 31, 2026, cash and cash equivalents were $24.8 million, with $0.4 million committed to future improvements in Ohio.
- 7
Total liquidity as of March 31, 2026, was $107.2 million, including cash and availability under the revolving credit facility.
Management Comments
Anthony Coniglio
Our first quarter results were in line with expectations, highlighted by 100% collection of contractual rent during the period. We remain focused on disciplined capital management and proactively reducing risk while improving the quality and resilience of our portfolio. The rescheduling of medical cannabis represents a historic shift in the federal government’s approach and is a pivotal moment for the industry. While implementation will take time and further guidance is needed from federal authorities, we believe increased regulatory clarity marks an important step forward and has the potential to strengthen the operating environment for our tenants.
Informational and educational content only. Not investment advice.